FDA Okays Empagliflozin for HFrEF FDA Okays Empagliflozin for HFrEF

The drug is approved as a treatment for adults with heart failure with reduced ejection fraction (HFrEF) regardless of whether patients have diabetes.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Alert Source Type: news